S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ADPT Adaptive Biotechnologies Corporation

4.91

-0.09 (-1.80%)

11 Oct 2024 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Sep 2024 to Oct 2024

Click Here for more Adaptive Biotechnologies Charts.

Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Oct 2023 to Oct 2024

Click Here for more Adaptive Biotechnologies Charts.

Adaptive Biotechnologies Corporation News

Form 4 - Statement of changes in beneficial ownership of securities
Friday 11 October 2024 (5 hours ago) • Edgar (US Regulatory)

Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024
Thursday 10 October 2024 (1 day ago) • GlobeNewswire Inc.

Adaptive Announces IVDR Certification for clonoSEQ® in European Union
Thursday 29 August 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 24 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 23 August 2024 (2 months ago) • Edgar (US Regulatory)

Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Friday 23 August 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 2 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 2 August 2024 (2 months ago) • Edgar (US Regulatory)

Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results
Friday 2 August 2024 (2 months ago) • GlobeNewswire Inc.

Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024
Friday 12 July 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 12 June 2024 (4 months ago) • Edgar (US Regulatory)

Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
Friday 31 May 2024 (4 months ago) • GlobeNewswire Inc.

More Adaptive Biotechnologies Corporation News Articles

Verizon Communications

Newcrest Mining

Gold vs US Dollar

Woodside Petroleum

Australian SE All Ordina...

Commonwealth Bank Of Aus...

Australia And New Zealan...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions